These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35816404)

  • 21. Chronic exposure of alcohol triggers microglia-mediated synaptic elimination inducing cognitive impairment.
    Lan L; Wang H; Zhang X; Shen Q; Li X; He L; Rong X; Peng J; Mo J; Peng Y
    Exp Neurol; 2022 Jul; 353():114061. PubMed ID: 35367455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of TREM2 accelerates the reduction of amyloid deposits and promotes neuronal regeneration in the hippocampus of amyloid beta1-42 injected mice.
    Fan Y; Ma Y; Huang W; Cheng X; Gao N; Li G; Tian S
    J Chem Neuroanat; 2019 Apr; 97():71-79. PubMed ID: 30790627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOE genotype and sex affect microglial interactions with plaques in Alzheimer's disease mice.
    Stephen TL; Cacciottolo M; Balu D; Morgan TE; LaDu MJ; Finch CE; Pike CJ
    Acta Neuropathol Commun; 2019 May; 7(1):82. PubMed ID: 31113487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
    von Saucken VE; Jay TR; Landreth GE
    Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute
    Schoch KM; Ezerskiy LA; Morhaus MM; Bannon RN; Sauerbeck AD; Shabsovich M; Jafar-Nejad P; Rigo F; Miller TM
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34187891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative Damage and Antioxidant Response in Frontal Cortex of Demented and Nondemented Individuals with Alzheimer's Neuropathology.
    Fracassi A; Marcatti M; Zolochevska O; Tabor N; Woltjer R; Moreno S; Taglialatela G
    J Neurosci; 2021 Jan; 41(3):538-554. PubMed ID: 33239403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TREM2 Overexpression has No Improvement on Neuropathology and Cognitive Impairment in Aging APPswe/PS1dE9 Mice.
    Jiang T; Wan Y; Zhang YD; Zhou JS; Gao Q; Zhu XC; Shi JQ; Lu H; Tan L; Yu JT
    Mol Neurobiol; 2017 Mar; 54(2):855-865. PubMed ID: 26780455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques.
    Natunen T; Martiskainen H; Marttinen M; Gabbouj S; Koivisto H; Kemppainen S; Kaipainen S; Takalo M; Svobodová H; Leppänen L; Kemiläinen B; Ryhänen S; Kuulasmaa T; Rahunen E; Juutinen S; Mäkinen P; Miettinen P; Rauramaa T; Pihlajamäki J; Haapasalo A; Leinonen V; Tanila H; Hiltunen M
    Mol Neurodegener; 2020 Nov; 15(1):66. PubMed ID: 33168021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
    Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
    Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
    Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
    J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent hypoxia training enhances Aβ endocytosis by plaque associated microglia via VPS35-dependent TREM2 recycling in murine Alzheimer's disease.
    Wang X; Xie Y; Fan X; Wu X; Wang D; Zhu L
    Alzheimers Res Ther; 2024 Jun; 16(1):121. PubMed ID: 38831312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.
    Teter B; Morihara T; Lim GP; Chu T; Jones MR; Zuo X; Paul RM; Frautschy SA; Cole GM
    Neurobiol Dis; 2019 Jul; 127():432-448. PubMed ID: 30951849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Trem2
    Tran KM; Kawauchi S; Kramár EA; Rezaie N; Liang HY; Sakr JS; Gomez-Arboledas A; Arreola MA; Cunha CD; Phan J; Wang S; Collins S; Walker A; Shi KX; Neumann J; Filimban G; Shi Z; Milinkeviciute G; Javonillo DI; Tran K; Gantuz M; Forner S; Swarup V; Tenner AJ; LaFerla FM; Wood MA; Mortazavi A; MacGregor GR; Green KN
    Mol Neurodegener; 2023 Feb; 18(1):12. PubMed ID: 36803190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models.
    Rueda-Carrasco J; Sokolova D; Lee SE; Childs T; Jurčáková N; Crowley G; De Schepper S; Ge JZ; Lachica JI; Toomey CE; Freeman OJ; Hardy J; Barnes SJ; Lashley T; Stevens B; Chang S; Hong S
    EMBO J; 2023 Oct; 42(19):e113246. PubMed ID: 37575021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration.
    Zhong L; Sheng X; Wang W; Li Y; Zhuo R; Wang K; Zhang L; Hu DD; Hong Y; Chen L; Rao H; Li T; Chen M; Lin Z; Zhang YW; Wang X; Yan XX; Chen X; Bu G; Chen XF
    Immunity; 2023 Aug; 56(8):1794-1808.e8. PubMed ID: 37442133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease.
    Perez SE; Nadeem M; He B; Miguel JC; Malek-Ahmadi MH; Chen K; Mufson EJ
    Neurobiol Aging; 2017 Jun; 54():133-143. PubMed ID: 28365005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease.
    Claes C; Danhash EP; Hasselmann J; Chadarevian JP; Shabestari SK; England WE; Lim TE; Hidalgo JLS; Spitale RC; Davtyan H; Blurton-Jones M
    Mol Neurodegener; 2021 Jul; 16(1):50. PubMed ID: 34301296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.
    McQuade A; Kang YJ; Hasselmann J; Jairaman A; Sotelo A; Coburn M; Shabestari SK; Chadarevian JP; Fote G; Tu CH; Danhash E; Silva J; Martinez E; Cotman C; Prieto GA; Thompson LM; Steffan JS; Smith I; Davtyan H; Cahalan M; Cho H; Blurton-Jones M
    Nat Commun; 2020 Oct; 11(1):5370. PubMed ID: 33097708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease.
    Zhao P; Xu Y; Jiang L; Fan X; Li L; Li X; Arase H; Zhao Y; Cao W; Zheng H; Xu H; Tong Q; Zhang N; An Z
    Sci Transl Med; 2022 Sep; 14(661):eabq0095. PubMed ID: 36070367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology.
    Wood JI; Wong E; Joghee R; Balbaa A; Vitanova KS; Stringer KM; Vanshoiack A; Phelan SJ; Launchbury F; Desai S; Tripathi T; Hanrieder J; Cummings DM; Hardy J; Edwards FA
    Cell Rep; 2022 Nov; 41(8):111686. PubMed ID: 36417868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.